0000950170-23-025373.txt : 20230531
0000950170-23-025373.hdr.sgml : 20230531
20230531163959
ACCESSION NUMBER: 0000950170-23-025373
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230526
FILED AS OF DATE: 20230531
DATE AS OF CHANGE: 20230531
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gibson Neil W
CENTRAL INDEX KEY: 0001555918
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39593
FILM NUMBER: 23981571
MAIL ADDRESS:
STREET 1: C/O REGULUS THERAPEUTICS INC.
STREET 2: 3545 JOHN HOPKINS COURT SUITE 210
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Shattuck Labs, Inc.
CENTRAL INDEX KEY: 0001680367
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 812575858
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 W. 5TH STREET
CITY: AUSTIN
STATE: TX
ZIP: 78701
BUSINESS PHONE: 512-900-4690
MAIL ADDRESS:
STREET 1: 500 W. 5TH STREET
CITY: AUSTIN
STATE: TX
ZIP: 78701
4
1
ownership.xml
4
X0407
4
2023-05-26
0001680367
Shattuck Labs, Inc.
STTK
0001555918
Gibson Neil W
C/O SHATTUCK LABS, INC.
500 W. 5TH STREET, SUITE 1200
AUSTIN
TX
78701
true
false
false
false
false
Stock Option (Right to Buy)
2.72
2023-05-26
4
A
false
40258
0.00
A
2033-05-26
Common Stock
40258
40258
D
This option represents the right to purchase a total of 40,258 shares of the Issuer's common stock, which will vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer.
/s/ Andrew R. Neill, Attorney-in-Fact for Neil W. Gibson
2023-05-31